Fuchs endothelial corneal dystrophy in patients with myotonic dystrophy: a case series

Devin Gattey1, Angela Y Zhu, Anna Stagner

  • 1*Casey Eye Institute, Oregon Health and Science University, Portland, OR; †Case Western Reserve University School of Medicine, Cleveland, OH; ‡Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE; §Devers Eye Institute, Portland, OR; and ¶Wilmer Eye Institute, Johns Hopkins Medical Institutions, Baltimore, MD.

Cornea
|November 26, 2013
PubMed
Abstract

Insights

Fuchs endothelial corneal dystrophy (FECD) was observed in four patients with myotonic dystrophy (DM). Potential shared mechanisms include protein expression, repeat expansion, or unfolded protein response pathways.

Area of Science:

  • Ophthalmology
  • Genetics
  • Corneal Diseases

Background:

  • Myotonic dystrophy (DM) is a multisystemic disorder.
  • Fuchs endothelial corneal dystrophy (FECD) affects the cornea.

Observation:

  • Four patients with DM were diagnosed with FECD.
  • All affected patients were female, aged 34-63; two were related.
  • Pathology confirmed FECD in corneal transplant specimens.

Findings:

  • This is the first reported association of FECD with DM.
  • The coexistence may be coincidental due to disease prevalence.
  • Shared pathogenic pathways are suggested.

Implications:

  • Potential links include ion homeostasis, repeat expansion, and stress responses.
  • Further research is needed to elucidate the association.
  • Understanding shared mechanisms could inform treatment strategies.